| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1045647850 |
| P356 | DOI | 10.1007/S12015-015-9618-4 |
| P698 | PubMed publication ID | 26323256 |
| P5875 | ResearchGate publication ID | 281519084 |
| P50 | author | Ali Khademhosseini | Q4724944 |
| Hojae Bae | Q88523613 | ||
| Serge Ostrovidov | Q56986099 | ||
| Sahar Salehi | Q41521155 | ||
| Toshinori Fujie | Q51121514 | ||
| P2093 | author name string | Xuetao Shi | |
| Murugan Ramalingam | |||
| Ramin Banan Sadeghian | |||
| P2860 | cites work | Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells | Q83023116 |
| Endogenous musculoskeletal tissue regeneration | Q83497474 | ||
| Bidirectional induction toward paraxial mesodermal derivatives from mouse ES cells in chemically defined medium | Q84510423 | ||
| The effect of matrix stiffness on mesenchymal stem cell differentiation in a 3D thixotropic gel | Q84663089 | ||
| Loss of dystrophin and β-sarcoglycan significantly exacerbates the phenotype of laminin α2 chain-deficient animals | Q87041814 | ||
| Injectable polyethylene glycol-fibrinogen hydrogel adjuvant improves survival and differentiation of transplanted mesoangioblasts in acute and chronic skeletal-muscle degeneration. | Q22001191 | ||
| Molecular and cell-based therapies for muscle degenerations: a road under construction | Q24568176 | ||
| Designing materials to direct stem-cell fate | Q24604904 | ||
| Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture | Q24623940 | ||
| A highly stable and nonintegrated human artificial chromosome (HAC) containing the 2.4 Mb entire human dystrophin gene | Q24631410 | ||
| Disease-specific induced pluripotent stem cells | Q24641981 | ||
| Myogenic specification of side population cells in skeletal muscle | Q24672806 | ||
| Derivation of multipotent mesenchymal precursors from human embryonic stem cells | Q24813785 | ||
| Myogenic Precursors from iPS Cells for Skeletal Muscle Cell Replacement Therapy | Q26799633 | ||
| Advancements in stem cells treatment of skeletal muscle wasting | Q26822437 | ||
| 25th anniversary article: Rational design and applications of hydrogels in regenerative medicine | Q26827960 | ||
| Lying low but ready for action: the quiescent muscle satellite cell | Q27012548 | ||
| Perspectives of stem cell therapy in Duchenne muscular dystrophy | Q27013613 | ||
| Materials as stem cell regulators | Q27021068 | ||
| Mechanical Characterization and Shape Optimization of Fascicle-Like 3D Skeletal Muscle Tissues Contracted with Electrical and Optical Stimuli | Q27306905 | ||
| Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro | Q27324593 | ||
| Characterization of dystrophin deficient rats: a new model for Duchenne muscular dystrophy | Q27335054 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Embryonic stem cell lines derived from human blastocysts | Q27861010 | ||
| Gene therapy approaches to regenerating the musculoskeletal system | Q28083399 | ||
| Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy | Q28084979 | ||
| 3D biofabrication strategies for tissue engineering and regenerative medicine | Q28241515 | ||
| A tunable silk-alginate hydrogel scaffold for stem cell culture and transplantation | Q37677874 | ||
| WNT3A promotes myogenesis of human embryonic stem cells and enhances in vivo engraftment | Q37737057 | ||
| Gradient biomaterials for soft-to-hard interface tissue engineering | Q37828248 | ||
| The tumorigenicity of human embryonic and induced pluripotent stem cells | Q37851350 | ||
| In situ guided tissue regeneration in musculoskeletal diseases and aging : Implementing pathology into tailored tissue engineering strategies | Q37947420 | ||
| Myoblast differentiation of human mesenchymal stem cells on graphene oxide and electrospun graphene oxide-polymer composite fibrous meshes: importance of graphene oxide conductivity and dielectric constant on their biocompatibility | Q57123439 | ||
| Genipin-crosslinked gelatin-silk fibroin hydrogels for modulating the behaviour of pluripotent cells | Q57216162 | ||
| Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: Implication for clinical trials | Q57261213 | ||
| Skeletal Muscle Differentiation of Embryonic Mesoangioblasts Requires Pax3 Activity | Q59484949 | ||
| Autologous Transplantation of Muscle-Derived CD133+ Stem Cells in Duchenne Muscle Patients | Q60313625 | ||
| Nanoscale surfaces for the long-term maintenance of mesenchymal stem cell phenotype and multipotency | Q60356330 | ||
| Human Ng2+ adipose stem cells loaded in vivo on a new crosslinked hyaluronic acid-lys scaffold fabricate a skeletal muscle tissue | Q60660400 | ||
| Identification and characterization of a non-satellite cell muscle resident progenitor during postnatal development | Q61781427 | ||
| Myoblast Transfer in the Treatment of Duchenne's Muscular Dystrophy | Q72000232 | ||
| 5-azacytidine induction of stable mesodermal stem cell lineages from 10T1/2 cells: Evidence for regulatory genes controlling determination | Q72747497 | ||
| Poly(ethylene glycol)-containing hydrogels in drug delivery | Q73076486 | ||
| Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs | Q28274324 | ||
| Nanocomposite hydrogels for biomedical applications | Q28302499 | ||
| Bioinspired Polymeric Nanocomposites for Regenerative Medicine | Q29012231 | ||
| Generation of mouse induced pluripotent stem cells without viral vectors | Q29614342 | ||
| Satellite cell of skeletal muscle fibers | Q29615148 | ||
| Membrane organization of the dystrophin-glycoprotein complex | Q29615149 | ||
| Immunogenicity of induced pluripotent stem cells | Q29616185 | ||
| Growth factors, matrices, and forces combine and control stem cells | Q29616603 | ||
| Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds | Q29616608 | ||
| Structure and dynamics of peptide-amphiphiles incorporating triple-helical proteinlike molecular architecture | Q30432646 | ||
| Combined hydrogels that switch human pluripotent stem cells from self-renewal to differentiation | Q30439799 | ||
| Asymmetric self-renewal and commitment of satellite stem cells in muscle. | Q30489194 | ||
| Formation and optogenetic control of engineered 3D skeletal muscle bioactuators | Q30537019 | ||
| Murine muscle engineered from dermal precursors: an in vitro model for skeletal muscle generation, degeneration, and fatty infiltration | Q30560376 | ||
| Derivation of myogenic progenitors directly from human pluripotent stem cells using a sphere-based culture | Q30577387 | ||
| Minimally invasive approach to the repair of injured skeletal muscle with a shape-memory scaffold | Q30650943 | ||
| Tunable shrink-induced honeycomb microwell arrays for uniform embryoid bodies | Q30881313 | ||
| Systemic delivery of human microdystrophin to regenerating mouse dystrophic muscle by muscle progenitor cells | Q33198739 | ||
| Micro- and nanoengineering approaches to control stem cell-biomaterial interactions | Q33649732 | ||
| A hybrid biomimetic scaffold composed of electrospun polycaprolactone nanofibers and self-assembled peptide amphiphile nanofibers | Q33681849 | ||
| 3D hydrogel environment rejuvenates aged pericytes for skeletal muscle tissue engineering | Q33687916 | ||
| Satellite cells and the muscle stem cell niche | Q33816665 | ||
| Hydrogels in pharmaceutical formulations | Q33935258 | ||
| Peptide-amphiphile nanofibers: a versatile scaffold for the preparation of self-assembling materials | Q34023617 | ||
| An acellular biologic scaffold promotes skeletal muscle formation in mice and humans with volumetric muscle loss | Q34040779 | ||
| Intramuscular transplantation of human postnatal myoblasts generates functional donor-derived satellite cells | Q34209805 | ||
| Dystrophin and mutations: one gene, several proteins, multiple phenotypes | Q34278933 | ||
| Selective differentiation of neural progenitor cells by high-epitope density nanofibers | Q34291910 | ||
| Skeletal muscle tissue engineering: methods to form skeletal myotubes and their applications | Q34322871 | ||
| Gene therapy for inherited muscle diseases: where genetics meets rehabilitation medicine | Q34340857 | ||
| Electrospun fibrous scaffolds with multiscale and photopatterned porosity | Q34495924 | ||
| Selective development of myogenic mesenchymal cells from human embryonic and induced pluripotent stem cells | Q34511100 | ||
| Muscle side population cells from dystrophic or injured muscle adopt a fibro-adipogenic fate | Q34555903 | ||
| Co-culture of human embryonic stem cells with murine embryonic fibroblasts on microwell-patterned substrates | Q34556138 | ||
| Gene therapy for muscular dystrophy: moving the field forward | Q34625436 | ||
| Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies. | Q37963087 | ||
| Pharmacological therapies for muscular dystrophies | Q38039926 | ||
| Gene therapy clinical trials worldwide to 2012 - an update. | Q38077166 | ||
| Non-viral gene delivery methods | Q38084337 | ||
| Cardiac and respiratory dysfunction in Duchenne muscular dystrophy and the role of second messengers. | Q38103213 | ||
| Skeletal muscle tissue engineering: which cell to use? | Q38107229 | ||
| Dystrophin complex functions as a scaffold for signalling proteins. | Q38135952 | ||
| Tissue engineering and regenerative medicine approaches to enhance the functional response to skeletal muscle injury | Q38167702 | ||
| New developments in the use of gene therapy to treat Duchenne muscular dystrophy | Q38168863 | ||
| Designing injectable, covalently cross-linked hydrogels for biomedical applications | Q38183325 | ||
| Material control of stem cell differentiation: challenges in nano-characterization | Q38212051 | ||
| Fetal stem cells and skeletal muscle regeneration: a therapeutic approach | Q38249175 | ||
| Human artificial chromosomes for Duchenne muscular dystrophy and beyond: challenges and hopes. | Q38321965 | ||
| What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease? | Q38351283 | ||
| Biomaterials based strategies for skeletal muscle tissue engineering: existing technologies and future trends | Q38428238 | ||
| Store-operated calcium entry contributes to abnormal Ca²⁺ signalling in dystrophic mdx mouse myoblasts. | Q38912120 | ||
| Myotube formation on gelatin nanofibers - multi-walled carbon nanotubes hybrid scaffolds | Q38994638 | ||
| Muscular dystrophy in a family of Labrador Retrievers with no muscle dystrophin and a mild phenotype | Q39024750 | ||
| Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers. | Q39044313 | ||
| Dielectrophoretically aligned carbon nanotubes to control electrical and mechanical properties of hydrogels to fabricate contractile muscle myofibers. | Q39135483 | ||
| Engineered nanomembranes for directing cellular organization toward flexible biodevices | Q39140664 | ||
| Myoblast differentiation on graphene oxide | Q39222285 | ||
| Synergic effects of nanofiber alignment and electroactivity on myoblast differentiation | Q39334632 | ||
| Proliferation and skeletal myotube formation capability of C2C12 and H9c2 cells on isotropic and anisotropic electrospun nanofibrous PHB scaffolds | Q39369067 | ||
| Clarifying misconceptions about myoblast transplantation in myology | Q39412916 | ||
| An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells | Q39456951 | ||
| Bioprinting of hybrid tissue constructs with tailorable mechanical properties | Q39539569 | ||
| Myogenic Induction of Aligned Mesenchymal Stem Cell Sheets by Culture on Thermally Responsive Electrospun Nanofibers | Q39602631 | ||
| Aligned electrospun polymer fibres for skeletal muscle regeneration | Q39704015 | ||
| Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability | Q39737560 | ||
| The stimulation of myoblast differentiation by electrically conductive sub-micron fibers | Q39894859 | ||
| Skeletal myogenesis on highly orientated microfibrous polyesterurethane scaffolds | Q40096776 | ||
| Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models | Q40181500 | ||
| Derivation of engraftable skeletal myoblasts from human embryonic stem cells | Q40225312 | ||
| In vitro differentiation of mouse embryonic stem (mES) cells using the hanging drop method | Q40240103 | ||
| Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells | Q40243228 | ||
| Skeletal myogenesis by human embryonic stem cells | Q40264797 | ||
| Myotube assembly on nanofibrous and micropatterned polymers | Q40307887 | ||
| Electrospinning polyaniline-contained gelatin nanofibers for tissue engineering applications | Q40340510 | ||
| Human myoblast transplantation: preliminary results of 4 cases | Q40734292 | ||
| Injectable thermosensitive chitosan/β-glycerophosphate/collagen hydrogel maintains the plasticity of skeletal muscle satellite cells and supports their in vivo viability. | Q34688374 | ||
| The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder | Q34692277 | ||
| Nanolithographic control of the spatial organization of cellular adhesion receptors at the single-molecule level. | Q34700615 | ||
| Fetal skeletal muscle progenitors have regenerative capacity after intramuscular engraftment in dystrophin deficient mice | Q34720948 | ||
| Strategies and new developments in the generation of patient-specific pluripotent stem cells | Q34764937 | ||
| Platelet-rich plasma promotes the proliferation of human muscle derived progenitor cells and maintains their stemness. | Q34769510 | ||
| Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery | Q35037783 | ||
| Syndecan-4-expressing muscle progenitor cells in the SP engraft as satellite cells during muscle regeneration. | Q35124906 | ||
| BIOMIMETIC GRADIENT HYDROGELS FOR TISSUE ENGINEERING. | Q35178509 | ||
| Complete restoration of multiple dystrophin isoforms in genetically corrected Duchenne muscular dystrophy patient-derived cardiomyocytes. | Q35194873 | ||
| Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs | Q35475301 | ||
| In vivo generation of a mature and functional artificial skeletal muscle | Q35483759 | ||
| Stem cell activation in skeletal muscle regeneration. | Q35547307 | ||
| Functional myogenic engraftment from mouse iPS cells. | Q35735727 | ||
| Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle | Q35835194 | ||
| Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice. | Q35947481 | ||
| Engineered composite tissue as a bioartificial limb graft. | Q36055333 | ||
| Muscle-derived stem cells for tissue engineering and regenerative therapy | Q36171454 | ||
| Designer self-assembling peptide nanofiber scaffolds for 3D tissue cell cultures | Q36215163 | ||
| Engineered contractile skeletal muscle tissue on a microgrooved methacrylated gelatin substrate | Q36408137 | ||
| Nano-featured scaffolds for tissue engineering: a review of spinning methodologies | Q36437166 | ||
| Skeletal myogenic differentiation of urine-derived stem cells and angiogenesis using microbeads loaded with growth factors | Q36443867 | ||
| The potential to improve cell infiltration in composite fiber-aligned electrospun scaffolds by the selective removal of sacrificial fibers. | Q36538989 | ||
| Development of a tissue-engineered vascular graft combining a biodegradable scaffold, muscle-derived stem cells and a rotational vacuum seeding technique. | Q36603422 | ||
| Engraftment of ES-Derived Myogenic Progenitors in a Severe Mouse Model of Muscular Dystrophy | Q36670780 | ||
| Embryonic and induced pluripotent stem cells: understanding, creating, and exploiting the nano-niche for regenerative medicine. | Q36723260 | ||
| Directed assembly of cell-laden microgels for fabrication of 3D tissue constructs | Q36775306 | ||
| Design strategies of tissue engineering scaffolds with controlled fiber orientation | Q36828786 | ||
| Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles | Q36879972 | ||
| Elastomeric Recombinant Protein-based Biomaterials | Q37074660 | ||
| Biology of the striated muscle dystrophin-glycoprotein complex | Q37085050 | ||
| Engineering controllable anisotropy in electrospun biodegradable nanofibrous scaffolds for musculoskeletal tissue engineering | Q37130496 | ||
| Electrospun scaffolds for stem cell engineering. | Q37568515 | ||
| Cell therapy strategies and improvements for muscular dystrophy. | Q37624403 | ||
| Skeletal muscle tissue engineering using isolated myoblasts on synthetic biodegradable polymers: preliminary studies | Q40785043 | ||
| Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. | Q40818700 | ||
| Porous gelatin hydrogels: 1. Cryogenic formation and structure analysis. | Q41624996 | ||
| Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9. | Q41873090 | ||
| A Perspective on the Potential of Human iPS Cell-Based Therapies for Muscular Dystrophies: Advancements so far and Hurdles to Overcome | Q42046048 | ||
| Phase separation, pore structure, and properties of nanofibrous gelatin scaffolds | Q42176782 | ||
| Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate. | Q42179070 | ||
| Muscle satellite cells adopt divergent fates: a mechanism for self-renewal? | Q42465353 | ||
| Multipotential mesoangioblast stem cell therapy in the mdx/utrn-/- mouse model for Duchenne muscular dystrophy | Q42512827 | ||
| Human umbilical cord stem cell encapsulation in novel macroporous and injectable fibrin for muscle tissue engineering | Q42521236 | ||
| Inhibition of apoptosis in human induced pluripotent stem cells during expansion in a defined culture using angiopoietin-1 derived peptide QHREDGS | Q42543495 | ||
| Effect of Electromechanical Stimulation on the Maturation of Myotubes on Aligned Electrospun Fibers | Q42546454 | ||
| Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy. | Q42819955 | ||
| Photocrosslinkable chitosan modified with angiopoietin-1 peptide, QHREDGS, promotes survival of neonatal rat heart cells | Q43030037 | ||
| Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts | Q43465378 | ||
| Porous biodegradable polymeric scaffolds prepared by thermally induced phase separation | Q43737967 | ||
| Intramuscular transplantation of myogenic cells in primates: importance of needle size, cell number, and injection volume | Q43837773 | ||
| Gold nanoparticle loaded hybrid nanofibers for cardiogenic differentiation of stem cells for infarcted myocardium regeneration | Q44772431 | ||
| In situ regeneration of skeletal muscle tissue through host cell recruitment | Q44879162 | ||
| Characterization of electrospun poly(L-lactide) and gold nanoparticle composite scaffolds for skeletal muscle tissue engineering | Q44967052 | ||
| Human mesenchymal stem cells ectopically expressing full-length dystrophin can complement Duchenne muscular dystrophy myotubes by cell fusion. | Q45888978 | ||
| Intrinsic cell memory reinforces myogenic commitment of pericyte-derived iPSCs | Q46093325 | ||
| The influence of the RGD peptide motif and its contextual presentation in PEG gels on human mesenchymal stem cell viability | Q46567746 | ||
| Stage-specific cardiomyocyte differentiation method for H7 and H9 human embryonic stem cells | Q46592531 | ||
| Synthetic nano-fibrillar extracellular matrices with predesigned macroporous architectures | Q46689206 | ||
| A thixotropic nanocomposite gel for three-dimensional cell culture | Q47249430 | ||
| Controlling size, shape and homogeneity of embryoid bodies using poly(ethylene glycol) microwells | Q47285716 | ||
| Efficient delivery of human single fiber-derived muscle precursor cells via biocompatible scaffold | Q47391015 | ||
| A normal life without muscle dystrophin | Q47571398 | ||
| The influence of electrospun aligned poly(epsilon-caprolactone)/collagen nanofiber meshes on the formation of self-aligned skeletal muscle myotubes | Q47783535 | ||
| The dystrophin / utrophin homologues in Drosophila and in sea urchin | Q48378746 | ||
| Formation of postsynaptic-like membranes during differentiation of embryonic stem cells in vitro. | Q48498555 | ||
| Hydrogels with integrin-binding angiopoietin-1-derived peptide, QHREDGS, for treatment of acute myocardial infarction. | Q48686101 | ||
| Dermal fibroblasts convert to a myogenic lineage in mdx mouse muscle. | Q49165636 | ||
| Fabrication and characterization of optogenetic, multi-strip cardiac muscles | Q50215624 | ||
| In vivo tissue engineering of functional skeletal muscle by freshly isolated satellite cells embedded in a photopolymerizable hydrogel. | Q50523990 | ||
| Efficient myogenic differentiation of murine dermal Sca-1 (−) cells via initial aggregation culture. | Q50688791 | ||
| Direct isolation of satellite cells for skeletal muscle regeneration. | Q50756094 | ||
| Cellular and molecular regulation of skeletal muscle side population cells. | Q50784645 | ||
| Formation of elongated fascicle-inspired 3D tissues consisting of high-density, aligned cells using sacrificial outer molding. | Q51517512 | ||
| Investigating the limits of filopodial sensing: a brief report using SEM to image the interaction between 10 nm high nano-topography and fibroblast filopodia. | Q51708742 | ||
| Functional skeletal muscle regeneration from differentiating embryonic stem cells. | Q51966818 | ||
| Modifications of collagen-based biomaterials with immobilized growth factors or peptides. | Q53515282 | ||
| Skeletal myogenic differentiation of human urine-derived cells as a potential source for skeletal muscle regeneration. | Q53521926 | ||
| Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. | Q54602083 | ||
| Nanofiber-based in vitro system for high myogenic differentiation of human embryonic stem cells. | Q54748253 | ||
| P433 | issue | 6 | |
| P921 | main subject | stem cell differentiation | Q14864672 |
| P304 | page(s) | 866-884 | |
| P577 | publication date | 2015-09-02 | |
| P1433 | published in | Stem Cell Reviews and Reports | Q7607285 |
| P1476 | title | Stem Cell Differentiation Toward the Myogenic Lineage for Muscle Tissue Regeneration: A Focus on Muscular Dystrophy | |
| P478 | volume | 11 |
| Q38793354 | Anisotropic Materials for Skeletal-Muscle-Tissue Engineering. |
| Q38748704 | Generation of human muscle fibers and satellite-like cells from human pluripotent stem cells in vitro |
| Q60908818 | Induced Pluripotent Stem Cells for Duchenne Muscular Dystrophy Modeling and Therapy |
| Q59357391 | Monitoring disease activity noninvasively in the model of Duchenne muscular dystrophy |
| Q58719281 | The Importance of Biophysical and Biochemical Stimuli in Dynamic Skeletal Muscle Models |
Search more.